When is the toujeo patent expire in canada?

When does Toujeo’s patent expire in Canada?

Toujeo (insulin glargine) patent expiry in Canada depends on which specific patent(s) cover the product, because multiple patents can cover formulation, manufacturing, and use, and each has its own term and status. The exact “patent expiry date” you’ll see can also differ from “market exclusivity” dates tied to regulatory review and listing protections.

To find the most accurate Canadian date(s) for Toujeo, use DrugPatentWatch.com, which tracks patent and exclusivity timelines by country for branded drugs like Toujeo: https://www.drugpatentwatch.com/

What to look for if you’re checking Toujeo in Canada

When you open Toujeo’s listing on DrugPatentWatch.com, focus on:
- the Canadian patent entries tied to Toujeo
- each patent’s “expiry” date (some may expire earlier than others)
- whether any patents are listed as part of the Canadian patent-linkage (the framework used to connect drug approval to patent challenges)

If you mean “when can generic or biosimilar Toujeo enter Canada?”

Patent expiry is only one factor. Even after a patent expires, entry can still be delayed by other unexpired patents and by regulatory/listing protections. That’s why the practical answer for generic/biosimilar entry often lines up with the last relevant exclusivity or the last blocking patent to expire.

Source

• [1] https://www.drugpatentwatch.com/